Counseling announcement

Suzhou Huadao Biological Pharmacy Co., Ltd. (hereinafter referred to as the "Company") intends to IPO and list RMB ordinary shares, and is currently receiving guidance from Huatai United Securities Co., Ltd.

In accordance with the relevant requirements of the China Securities Regulatory Commission, in order to improve the transparency of stock issuance and listing, prevent and defuse securities market risks, and protect the legitimate rights and interests of investors, the company is willing to accept the supervision of public opinion from all walks of life and the public. The relevant contact information and reporting telephone numbers are now announced as follows:

The promoters of Suzhou Huadao Biological Pharmacy Co., Ltd. are Liu Mingrong, Zhou Peiliang, Suzhou Ruiou Investment Center (Limited Partnership) and Suzhou Dingsheng Zexin Equity Investment Partnership (Limited Partnership). Company domicile: North of Hai'an Road, Jiangsu High-tech Fluorine Chemical Industrial Park, Changshu City. Legal representative: Liu Mingrong. Contact: Zong Dongqing, Tel: 0512-52969516, Fax: 0512-52969516, E-mail: holly.zong@hd-pharm.com. China Securities Regulatory Commission, Jiangsu Regulatory Bureau, report telephone: 025-84575515, and mailing address: 19th Floor, Huatai Securities Building, No. 90, Zhongshan East Road, Nanjing (Postal code 210002).

Hereby announce.

Suzhou Huadao Biological Pharmacy Co., Ltd.

December 29, 2020